For me, this is the key takeaway "Most countries are now operating at or near full capacity with government restrictions being eased or removed".
The paper based test volume is back at pre-COVID levels, and computer-delivered tests significantly higher.
The share price reflects forward looking view - looking at historical numbers in a COVID-affected industry is not particularly meaningful.
Market seems to agree
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$3.62 |
Change
-0.080(2.16%) |
Mkt cap ! $1.010B | |||
| Open | High | Low | Value | Volume |
| $3.67 | $3.68 | $3.56 | $8.853M | 2.454M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $3.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.63 | 11600 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| IEL (ASX) Chart |